Your browser doesn't support javascript.
loading
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†.
van Rhijn, Bas W G; Mertens, Laura S; Mayr, Roman; Bostrom, Peter J; Real, Francisco X; Zwarthoff, Ellen C; Boormans, Joost L; Abas, Cheno; van Leenders, Geert J L H; Götz, Stefanie; Hippe, Katrin; Bertz, Simone; Neuzillet, Yann; Sanders, Joyce; Broeks, Annegien; van der Heijden, Michiel S; Jewett, Michael A S; Marquez, Mirari; Stoehr, Robert; Zlotta, Alexandre R; Eckstein, Markus; Soorojebally, Yanish; Roshani, Hossain; Burger, Maximilian; Otto, Wolfgang; Radvanyi, François; Sirab, Nanor; Pouessel, Damien; Wullich, Bernd; van der Kwast, Theo H; Malats, Núria; Hartmann, Arndt; Allory, Yves; Zuiverloon, Tahlita C M.
  • van Rhijn BWG; Departments of Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Cari
  • Mertens LS; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Mayr R; Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Bostrom PJ; Departments of Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada; Department of Urology, Turku University Hospital and University of Turku, Turku, Finland.
  • Real FX; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre (CNIO) & CIBERONC, Madrid, Spain; Department of de Ciències Experimentals i de la Salut, University Pompeu Fabra, Barcelona, Spain.
  • Zwarthoff EC; Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands.
  • Boormans JL; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Abas C; Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands.
  • van Leenders GJLH; Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
  • Götz S; Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Hippe K; Department of Pathology, University Medical Center-Regensburg, Regensburg, Germany.
  • Bertz S; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nürnberg, Erlangen, Germany.
  • Neuzillet Y; Department of Urology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Sanders J; Core Facility Molecular Pathology & Biobank, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Broeks A; Core Facility Molecular Pathology & Biobank, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • van der Heijden MS; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Jewett MAS; Departments of Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Marquez M; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Stoehr R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nürnberg, Erlangen, Germany.
  • Zlotta AR; Departments of Surgery (Urology) and Surgical Oncology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nürnberg, Erlangen, Germany.
  • Soorojebally Y; Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France.
  • Roshani H; Department of Urology, Haga Ziekenhuis, The Hague, The Netherlands.
  • Burger M; Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Otto W; Department of Urology, Caritas St Josef Medical Center, University of Regensburg, Regensburg, Germany.
  • Radvanyi F; Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France.
  • Sirab N; Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France.
  • Pouessel D; Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France; Department of Medical Oncology, Claudius Regaud Institute, Toulouse University Cancer Center (IUCT) Oncopole, Toulouse, France.
  • Wullich B; Department of Urology & Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nürnberg, Erlangen, Germany.
  • van der Kwast TH; Department of Pathology, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Malats N; Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen/Nürnberg, Erlangen, Germany.
  • Allory Y; Institut Curie, CNRS, UMR144, Molecular Oncology Team, PSL Research University, Paris, France; Department of Pathology, Institut Curie, Paris, France.
  • Zuiverloon TCM; Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands; Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands. Electronic address: t.zuiverloon@erasmusmc.nl.
Eur Urol ; 78(5): 682-687, 2020 11.
Article en En | MEDLINE | ID: mdl-32682615
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cistectomía / Regulación Neoplásica de la Expresión Génica / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Mutación Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Cistectomía / Regulación Neoplásica de la Expresión Génica / Receptor Tipo 3 de Factor de Crecimiento de Fibroblastos / Mutación Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article